Krsnaa Diagnostics Ltd
NSE:KRSNAA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Krsnaa Diagnostics Ltd
Free Cash Flow
Krsnaa Diagnostics Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Krsnaa Diagnostics Ltd
NSE:KRSNAA
|
Free Cash Flow
-₹393m
|
CAGR 3-Years
-118%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Dr Agarwal's Eye Hospital Ltd
BSE:526783
|
Free Cash Flow
₹137.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thyrocare Technologies Ltd
NSE:THYROCARE
|
Free Cash Flow
₹1.8B
|
CAGR 3-Years
33%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
Free Cash Flow
₹4.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
|
Free Cash Flow
₹1.3B
|
CAGR 3-Years
53%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
Free Cash Flow
₹1.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Krsnaa Diagnostics Ltd
Glance View
Krsnaa Diagnostics Ltd. engages in the provision of diagnostics services. The company is headquartered in Pune, Maharashtra. The company went IPO on 2021-08-16. The firm is focused on providing radiology and pathology services for -radiation (X-rays), computed tomography (CT) scan, magnetic resonance imaging (MRI), mammography, tele- reporting services, and all types of blood and urine investigation. The firm operates within India and has diagnostic centers all over India. The Company' studies in CT Scan include Peripheral Angio, Urography, Coronary Angio, Cisternography, CT Brain, CT Abdomen Triple Phase, CT HRCT Temporal Bone, CT Dentascan, CT Brain Angio, CT Perfusion, CT Renal Angio, CT Aortography and CT Pulmonary Angio. The Company’s services in color doppler include upper limb arterial doppler, upper limb venous doppler, lower limb arterial doppler, lower limb venous doppler, carotid doppler, hepatosplenic doppler, obstetric doppler and scrotal doppler.
See Also
What is Krsnaa Diagnostics Ltd's Free Cash Flow?
Free Cash Flow
-393m
INR
Based on the financial report for Mar 31, 2025, Krsnaa Diagnostics Ltd's Free Cash Flow amounts to -393m INR.
What is Krsnaa Diagnostics Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
0%
Over the last year, the Free Cash Flow growth was 77%. The average annual Free Cash Flow growth rates for Krsnaa Diagnostics Ltd have been -118% over the past three years .